Psychedelic Medicine

Association

Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo

Excerpts from the publication

Summary
Psilocybin is a serotonergic psychedelic with untapped therapeutic potential. There are hints that the use of psychedelics can produce neural adaptations, although the extent and timescale of the impact in a mammalian brain are unknown. In this study, we used chronic two-photon microscopy to image longitudinally the apical dendritic spines of layer 5 pyramidal neurons in the mouse medial frontal cortex. We found that a single dose of psilocybin led to ∼10% increases in spine size and density, driven by an elevated spine formation rate. The structural remodeling occurred quickly within 24 h and was persistent 1 month later. Psilocybin also ameliorated stress-related behavioral deficit and elevated excitatory neurotransmission. Overall, the results demonstrate that psilocybin-evoked synaptic rewiring in the cortex is fast and enduring, potentially providing a structural trace for long-term integration of experiences and lasting beneficial actions

Read more

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial

Dose-response relationships of LSD-induced subjective experiences in humans

Psychedelic-Assisted Group Therapy: A Systematic Review

Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review

Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis

Medical student attitudes and perceptions of psychedelic-assisted therapies